Blog

No Comments

Mission Pharma Achieves Top Ranking by Saudi FDA in 2023

Mission Pharma Achieves Top Ranking by Saudi FDA in 2023 Mission Pharma has been ranked #2 by the Saudi Food and Drug Authority (sFDA) in 2023 for its proactive efforts in submitting regulatory dossiers for market shortage products, reaffirming its commitment to addressing critical pharmaceutical needs in the Kingdom.

No Comments

10-Year Exclusive Distribution Agreement

Mission Pharma Secures 10-Year Exclusive Distribution Agreement with Amneal Healthcare: Mission Pharma has successfully amended its exclusive distribution agreement with Amneal Healthcare Private Limited, extending the partnership to a 10-year term for the specified product. This strategic amendment reinforces our long-term collaboration and reflects our mutual commitment to sustained growth and market presence. Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

No Comments

Strategic Contribution to Egypt’s COVID-19 Response

Strategic Contribution to Egypt’s COVID-19 Respons Mission Pharma successfully supported Egyptian health authorities during the COVID-19 pandemic by ensuring the supply of the country’s first Enoxaparin biosimilars, playing a pivotal role in maintaining access to essential anticoagulant therapies during a time of global uncertainty.